logo

For the Inventor, By the Inventor

Athens, Greece

Nikolaos Lougiakis

This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Beckman Research Institute, City of Hope, National and Kapodistrian University of Athens, The University of Manchester. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaos Lougiakis. Retrieved from https://idiyas.com/inventor/nikolaos-lougiakis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 692 
 
Beckman Research Institute, City of Hope
 patents
silverMedal2 out of 8 
 
National and Kapodistrian University of Athens
 patents
bronzeMedal2 out of 233 
 
The University of Manchester
 patents
4. 1 out of 108 
 
University of Dundee
 patents
where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 12496361 - Imaging compounds for detecting or imaging senescent cells (2025-12-16),
2. 11213510 - Thioindirubins (2022-01-04),
3. 11117894 - Pyridopyrazine compounds and uses thereof (2021-09-14),
4. 11034839 - Compounds, linked with haptens, for the detection of senescent cells (2021-06-15),
5. 10947390 - Compounds for the detection of senescent cells (2021-03-16),

Title: Innovations and Contributions of Nikolaos Lougiakis

Introduction

Nikolaos Lougiakis is a prominent inventor based in Athens, Greece. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of four patents to his name, Lougiakis continues to push the boundaries of scientific discovery.

Latest Patents

Among his latest patents, Lougiakis has developed thioindirubins, which are compositions and methods for treating cancer using thioindirubin derivatives. Additionally, he has worked on pyridopyrazine compounds, disclosing methods of using these compounds for various applications. These innovations reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Lougiakis has had a distinguished career, working with esteemed institutions such as the University of Manchester and City of Hope. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Nicole Pouli and Vassilis Gorgoulis. Their collaborative efforts have further enhanced the impact of Lougiakis's research and innovations.

Conclusion

Nikolaos Lougiakis is a dedicated inventor whose work in cancer treatment showcases his innovative spirit and commitment to scientific advancement. His contributions continue to inspire future research and development in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…